Human urinary kallidinogenase in treating acute ischemic stroke patients: analyses of pooled data from a randomized double-blind placebo-controlled phase IIb and phase III clinical trial.

Conclusion: HUK is safe and provides potential clinical benefits as a treatment for acute ischemic stroke. Further large post-marketing observational studies are needed. PMID: 32138624 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32138624?dopt=Abstract

Source: Neurological Research - March 7, 2020 Category: Neurology Tags: Neurol Res Source Type: research